Work

Correlative analysis of ctDNA in CheckMate-9X8 study of frontline treatment with mFOLFOX6, bevacizumab with or without nivolumab in metastatic colorectal cancer.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3584

Authors: Jin Yao, Yong Huang, Rachel Tam, Amanda Cruz, Reed Selby, Aparna Raj Parikh, Takayuki Yoshino, Josep Tabernero, Shidong Jia, Ruslan Novosiadly, Heinz-Josef Lenz

Institutions: Bristol-Myers Squibb (United States), Harvard University, Mass General Brigham, National Cancer Center Hospital East, Vall d'Hebron Institute of Oncology, USC Norris Comprehensive Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162494668

Cites:

Cited by:

Related to: